media – Page 20 – Pharma & Medical Industry Insights Hub | Drugdu Insights & Updates

The 100 billion yuan autoimmune disease prevention market, the next outbreak point

In the field of autoimmune therapy, traditional biologics have long dominated the market. Although classic drugs represented by Humira have significant therapeutic effects, they have limitations such as the need for frequent injections and potential risks of infection, which lead to low patient compliance. In sharp contrast, oral autoimmune drugs are rising rapidly and becoming the next explosion point in the industry due to their multiple advantages such as convenient home administration, no need for cold chain transportation, and controllable production costs. The next hot spot Globally, there are approximately 100 different types of autoimmune diseases, which can affect almost any part of the body, from the skin to the joints to the digestive system. Epidemiological data show that the patient population covered by major indications such as psoriasis, atopic dermatitis, and asthma has exceeded 100 million, constituting the core treatment needs in the autoimmune field. According to Frost & ...
- Source: drugdu
- 67
- May 8, 2025
Medical research has found that those who did not develop lung cancer despite having pneumonia all had these three dietary habits.

The lungs have just gone through a “storm”, and the worst thing is to leave behind hidden problems. Those who have recovered from pneumonia and have maintained a safe distance from lung cancer have secrets hidden in their plates. The latest medical observation has found that three “lung protectors” always appear on the diet lists of these people. I. The “Antioxidant Trio” Always Present on the Table 1. The protective shield of chlorophyll in dark-colored vegetables Consume at least 200 grams of dark green vegetables such as spinach and broccoli every day. These vegetables are rich in chlorophyll, which can neutralize free radicals produced by lung inflammation. The recommended cooking method is cold preparation to retain the maximum nutrients. 2. The natural anti-inflammatory agents in colorful fruits and vegetables The carotenoids in red and yellow fruits and vegetables, as confirmed by research, can reduce the risk of lung cancer. Eat ...
- Source: drugdu
- 58
- May 8, 2025
Exercising just one or two days a week can also lead to long-term health benefits.

The latest research by Chinese scientists shows that people can achieve the health benefits of daily exercise by engaging in physical activities for moderate to vigorous intensity for 1 to 2 days a week, as long as the total duration is at least 150 minutes per week. This research report was published in the recent issue of the “American Heart Association Journal”. Dr. Li Zhihao, an epidemiologist from Southern Medical University in Guangzhou, said that engaging in 150 minutes of moderate to vigorous physical activity per week, whether concentrated in 1 to 2 days or spread out over time, can significantly reduce the risk of death from cardiovascular diseases, cancer, or other causes. Those who cannot schedule physical exercise every day can focus on high-intensity activities on weekends. This study provides reliable evidence that even occasional physical activity can bring long-term health benefits, making it easier for people to prioritize ...
- Source: drugdu
- 61
- May 8, 2025
Tecnosalud

Organiser：TECNOSALUD AREQUIPA Time：September 10th – 12th, 2025 address：Av. Javier Prado Este 4200, Santiago de Surco, Lima, Peru Exhibition hall：Jockey Plaza Product range: Medical Equipment & Devices: Diagnostic equipment and instruments, emergency equipment, respiratory devices, imaging equipment, dialysis equipment, etc. Medical Consumables: Bandages, gauze, endoscopes, staplers, etc. Dental Products: Dental diagnostic equipment, dental handpieces, periodontal examination systems, dental surgical equipment, dental anesthesia devices, periodontal materials, etc. Pharmaceuticals: Pharmaceuticals, anesthetics, raw materials, intermediates, biological agents, chemicals, health products, and dietary supplements, etc. Laboratory Products: Laboratory instruments and equipment, optical instruments, image analysis and processing systems, testing instruments and devices, laboratory renovation and upgrade technologies, consumables, and related software, etc. Others: Rehabilitation products and hospital furniture, physiotherapy, medical automation, environmental health, medical tourism services, medical consulting services, medical publications, etc. About Tecnosalud： The Tecnosalud Medical Exhibition in Lima, Peru, is the most renowned medical equipment exhibition in Peru. It showcases the ...
- Source: drugdu
- 113
- May 8, 2025
The Neuralink brain computer interface device has obtained FDA’s “Breakthrough Device” certification; Hengrui Pharmaceutical Passes Hong Kong Stock Exchange Listing Hearing | Pharmaceutical Early Participation

NO.1 Hengrui Pharmaceutical has passed the listing hearing on the Hong Kong Stock Exchange and may be listed as early as May On May 5th, the Hong Kong Stock Exchange website posted the PHIP version of Hengrui Pharmaceutical’s prospectus, which the market interpreted as indicating that Hengrui Pharmaceutical has officially passed the hearing of the Hong Kong Stock Exchange. Hengrui Pharmaceutical told the Daily Economic News reporter that this move marks a crucial progress for the company’s listing in Hong Kong. According to informed sources, Hengrui Pharmaceutical may be officially listed and traded on the Hong Kong Stock Exchange as early as May. Commentary: If Hengrui Pharmaceutical successfully goes public on the Hong Kong stock market this time, it will be its first equity financing after its A-share IPO and a key milestone in its internationalization strategy. From the current development trend of the pharmaceutical industry, overseas markets have ...
- Source: drugdu
- 70
- May 7, 2025
21 Health News Daily | The actual controller and chairman of Yong’an Pharmaceutical have been detained; Ha Sanlian and related personnel received a warning letter from Heilongjiang Securities Regulatory Bureau

Large expansion of grassroots drug catalog On April 30th, the National Health Commission issued the “Guiding Opinions on Optimizing the Layout and Construction of Grassroots Medical and Health Institutions”, once again clarifying the need to expand the types of drugs used for common and chronic diseases at the grassroots level, and promote the unification of drug catalogs for county-level medical communities. The Opinion guides various regions to comprehensively coordinate the development of urban-rural integration, changes in population structure, and public health needs, and to improve the layout and construction of grassroots medical and health institutions according to local conditions. This is in line with the State Council executive meeting’s proposal to “improve the construction layout according to local conditions”. The core goal of the policy is to optimize resource allocation and improve service capabilities, promote the implementation of tiered diagnosis and treatment, and achieve a medical pattern of “minor ...
- Source: drugdu
- 83
- May 7, 2025
【EXPERT Q&A】What regulations and guiding principles are there for OOS investigations in pharmaceutical enterprises?

Drugdu.com expert’s response: Pharmaceutical companies are required to adhere to a series of regulations and guidelines when conducting investigations into Out-of-Specification (OOS) results. These documents provide a clear framework for the investigation process, responsibility allocation, and subsequent handling. The specifics are as follows: I. Core Regulatory Requirements FDA Regulations 21 CFR Part 211: Clearly stipulates Current Good Manufacturing Practices (CGMP) for pharmaceutical production and quality control, mandating the recording and investigation of any laboratory results that do not meet quality standards. FDA 211.192: Requires thorough investigations into OOS results. Even if a batch is rejected due to OOS, it is still necessary to determine whether the result is associated with other drugs or batches. FDA 211.194: Specifies that written records of investigations must include conclusions and follow-up actions to ensure process traceability. China GMP (Revised 2010 Edition): Article 224 mandates that quality control laboratories establish operating procedures for investigating out-of-specification ...
- Source: drugdu
- 79
- May 7, 2025
The Neuralink brain computer interface device has obtained FDA’s “Breakthrough Device” certification; Hengrui Pharmaceutical Passes Hong Kong Stock Exchange Listing Hearing | Pharmaceutical Early Participation

NO.1 Hengrui Pharmaceutical has passed the listing hearing on the Hong Kong Stock Exchange and may be listed as early as May On May 5th, the Hong Kong Stock Exchange website posted the PHIP version of Hengrui Pharmaceutical’s prospectus, which the market interpreted as indicating that Hengrui Pharmaceutical has officially passed the hearing of the Hong Kong Stock Exchange. Hengrui Pharmaceutical told the Daily Economic News reporter that this move marks a crucial progress for the company’s listing in Hong Kong. According to informed sources, Hengrui Pharmaceutical may be officially listed and traded on the Hong Kong Stock Exchange as early as May. Commentary: If Hengrui Pharmaceutical successfully goes public on the Hong Kong stock market this time, it will be its first equity financing after its A-share IPO and a key milestone in its internationalization strategy. From the current development trend of the pharmaceutical industry, overseas markets have ...
- Source: drugdu
- 81
- May 7, 2025
21 Health News Daily | The actual controller and chairman of Yong’an Pharmaceutical have been detained; Ha Sanlian and related personnel received a warning letter from Heilongjiang Securities Regulatory Bureau

On April 30th, the National Health Commission issued the “Guiding Opinions on Optimizing the Layout and Construction of Grassroots Medical and Health Institutions”, once again clarifying the need to expand the types of drugs used for common and chronic diseases at the grassroots level, and promote the unification of drug catalogs for county-level medical communities. The Opinion guides various regions to comprehensively coordinate the development of urban-rural integration, changes in population structure, and public health needs, and to improve the layout and construction of grassroots medical and health institutions according to local conditions. This is in line with the State Council executive meeting’s proposal to “improve the construction layout according to local conditions”. The core goal of the policy is to optimize resource allocation and improve service capabilities, promote the implementation of tiered diagnosis and treatment, and achieve a medical pattern of “minor illnesses not leaving the village and ...
- Source: drugdu
- 75
- May 7, 2025
ExpoMedical

Organiser：ExpoMedical Time：September 24-26, 2025 address：Av. Costanera R. Obligado and J. Salguero, Buenos Aires, Argentina Exhibition hall：Costa Salguero Exhibition Center Product range: Medical Equipment: Medical devices, electronic medical equipment, diagnostic instruments for various departments, testing instruments, medical optical instruments, X-ray equipment, imaging devices, scanning equipment, MRI machines, ultrasound diagnostic tools, clinical laboratory analysis instruments, hemodialysis equipment, dental equipment, anesthesia and respiratory devices, interventional diagnostic tools, dialysis equipment, etc. Medical Supplies: Disposable medical supplies, consumables, syringes, blood transfusion sets, sanitary napkins, band-aids, face masks, bandages, stethoscopes, medical ambulances, operating room supplies, scrubs, medical kits, gloves, various surgical knives, forceps, scissors, dental and orthopedic grinding/drilling tools, small electronic instruments, testing devices and accessories, orthopedic surgical technologies, medical beds, surgical and disinfection supplies, cleaning technologies, ambulance supplies, bandages, wound dressings, etc. First Aid Supplies: First aid equipment, emergency response devices, pharmaceutical products, medications, infusion solutions, disinfectants, blood derivatives, nutritional supplements, dermatological medications, veterinary ...
- Source: drugdu
- 98
- May 6, 2025

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.